Melatonin and Nattokinase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Melatonin (melatonin) and Nattokinase (nattokinase). Common drug interactions include supraventricular tachycardia among females and anaesthetic complication among males.

The phase IV clinical study analyzes what interactions people have when they take Melatonin and Nattokinase. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Melatonin?

Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,212 Melatonin users. Check the latest studies of Melatonin.

What is Nattokinase?

Nattokinase has active ingredients of nattokinase. It is often used in blood clots. eHealthMe is studying from 227 Nattokinase users. Check the latest studies of Nattokinase.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 18, 2026

21 people who take Melatonin and Nattokinase together, and have interactions are studied.

Melatonin and Nattokinase drug interactions.

What are the common drug interactions of Melatonin and Nattokinase, by gender? *:

female:

  1. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  2. Cough
  3. Dizziness
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Hypotension (abnormally low blood pressure)
  7. Myalgia (muscle pain)
  8. Red blood cell sedimentation rate increased
  9. Alpha 1 globulin increased
  10. Alpha 2 globulin increased

male:

  1. Anaesthetic complication
  2. Colorectal cancer (colon cancer or bowel cancer)
  3. Death
  4. Abdominal distension
  5. Anaemia (lack of blood)
  6. Fatigue (feeling of tiredness)
  7. Oedema (fluid collection in tissue)
  8. Renal impairment (severely reduced kidney function)

What are the common drug interactions of Melatonin and Nattokinase, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anaesthetic complication
  2. Colorectal cancer (colon cancer or bowel cancer)

60+:

  1. Death
  2. Myalgia (muscle pain)
  3. Fatigue (feeling of tiredness)
  4. Gait disturbance
  5. Headache (pain in head)
  6. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  7. Lymphocyte count decreased
  8. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  9. Pain
  10. Pain in extremity

What are the existing conditions these people have? *

  1. Headache (pain in head): 5 people, 23.81%
  2. Type 2 Diabetes: 4 people, 19.05%
  3. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 19.05%
  4. Cardiac Disorder: 4 people, 19.05%
  5. Constipation: 4 people, 19.05%
  6. Cryofibrinogenaemia (the presence of cryofibrinogen in the blood): 4 people, 19.05%
  7. Depression: 4 people, 19.05%
  8. Diabetes: 4 people, 19.05%
  9. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 19.05%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 19.05%

* Approximation only. Some reports may have incomplete information.

Do you take Melatonin and Nattokinase?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Melatonin and Nattokinase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nattokinase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Melatonin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nattokinase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on melatonin and nattokinase (the active ingredients of Melatonin and Nattokinase, respectively), and Melatonin and Nattokinase (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: